MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus

NCT03567824 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypomagnesemia in Type 2 Diabetic Patients

Interventions

DRUG: Magnesium L-lactate dihydrate
DRUG: Placebo Oral Tablet

Sponsor

Pharmalyte Solutions LLC